Arne von Bonin, PhD Vaxxilon

Arne has more than 15 years of industrial experience in Inflammation & Immunology Research. He has a thorough background in preclinical development of small molecule, antibody and vaccine related therapeutics. His spectrum of activities includes target & lead identification, optimization and the support of advanced clinical development programs.

Before joining Vaxxilon in 2016, Arne was the CSO and a board member of AFFiRiS, Vienna and worked from 2003 until 2012 in different R&D related functions at Bayer Healthcare AG (before Schering AG, Berlin).

Arne holds a PhD in Biology (Max-Planck Institute for Immunobiology, Freiburg, Germany). His long-standing interest is Immunology with a specific focus on T cell mediated immune regulation.